Revista Portuguesa de Pneumologia (English Edition)最新文献

筛选
英文 中文
Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence 抗纤维化治疗时代的特发性肺纤维化:寻找基于证据的新机会
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-09-01 DOI: 10.1016/j.rppnen.2017.05.005
C. Robalo-Cordeiro , P. Campos , L. Carvalho , A. Borba , S. Clemente , S. Freitas , S. Furtado , J.M. Jesus , C. Leal , A. Marques , N. Melo , C. Souto-Moura , S. Neves , V. Sousa , A. Santos , A. Morais
{"title":"Idiopathic pulmonary fibrosis in the era of antifibrotic therapy: Searching for new opportunities grounded in evidence","authors":"C. Robalo-Cordeiro ,&nbsp;P. Campos ,&nbsp;L. Carvalho ,&nbsp;A. Borba ,&nbsp;S. Clemente ,&nbsp;S. Freitas ,&nbsp;S. Furtado ,&nbsp;J.M. Jesus ,&nbsp;C. Leal ,&nbsp;A. Marques ,&nbsp;N. Melo ,&nbsp;C. Souto-Moura ,&nbsp;S. Neves ,&nbsp;V. Sousa ,&nbsp;A. Santos ,&nbsp;A. Morais","doi":"10.1016/j.rppnen.2017.05.005","DOIUrl":"10.1016/j.rppnen.2017.05.005","url":null,"abstract":"<div><p>Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that up to now has been associated with a poor prognosis. However, the results of the INPULSIS and ASCEND trials and the approval of nintedanib and pirfenidone have marked the beginning of a new era for IPF patients. Questions remain, however. Should these drugs be used earlier? What effect will they have on more severe disease? Will their effects last beyond the trial period? This manuscript is the outcome of a multidisciplinary meeting between pulmonology, radiology, and pathology clinicians on the use of antifibrotic agents in IPF. In our opinion, the existing data show that pirfenidone and nintedanib slow functional decline in early stages of disease. These drugs also appear to result in therapeutic benefits when administered to patients with advanced disease at diagnosis and maintain effective over time. The data also suggest that continuing antifibrotic therapy after disease progression may confer benefits, but more evidence is needed. Early diagnosis and treatment are crucial for reducing functional decline, slowing disease progression, and improving quality of life.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 5","pages":"Pages 287-293"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35136994","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis 在临床实践中使用证据:特发性肺纤维化的梦想成真
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-09-01 DOI: 10.1016/j.rppnen.2017.08.005
G. Sgalla, L. Richeldi
{"title":"Using evidence in clinical practice: A dream coming true in idiopathic pulmonary fibrosis","authors":"G. Sgalla,&nbsp;L. Richeldi","doi":"10.1016/j.rppnen.2017.08.005","DOIUrl":"10.1016/j.rppnen.2017.08.005","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 5","pages":"Pages 245-246"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.08.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35415639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test 在6分钟步行试验和增量跑步机心肺运动试验中评估慢性阻塞性肺疾病男性患者的呼吸困难和动态恶性膨胀
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-09-01 DOI: 10.1016/j.rppnen.2017.04.007
M. Alfonso , V. Bustamante , P. Cebollero , M. Antón , S. Herrero , J.B. Gáldiz
{"title":"Assessment of dyspnea and dynamic hyperinflation in male patients with chronic obstructive pulmonary disease during a six minute walk test and an incremental treadmill cardiorespiratory exercise test","authors":"M. Alfonso ,&nbsp;V. Bustamante ,&nbsp;P. Cebollero ,&nbsp;M. Antón ,&nbsp;S. Herrero ,&nbsp;J.B. Gáldiz","doi":"10.1016/j.rppnen.2017.04.007","DOIUrl":"10.1016/j.rppnen.2017.04.007","url":null,"abstract":"<div><p>The six minute walk test (6MWT) is a standardized test that provides information on exercise capacity in patients with COPD. It is considered a submaximal test in opposition to incremental cardiopulmonary exercise tests (CPET) that provide valuable information on all the systems involved in exercise.</p></div><div><h3>Objectives</h3><p>1. To compare the perceptive, physiological responses and degree of dynamic hyperinflation during two exercise tests: the 6MWT and the incremental CPET on a treadmill. 2. To evaluate how dyspnea is related to dynamic hyperinflation (DH) and other functional parameters in both tests.</p></div><div><h3>Methods</h3><p>29 stable COPD male patients, age 68<!--> <!-->±<!--> <!-->5.8 years, mean post-bronchodilator FEV1 57<!--> <!-->±<!--> <!-->11%, were recruited. To evaluate dynamic hyperinflation, inspiratory capacity (IC) was measured at rest and upon completing each one of the tests. At the same time, perceived dyspnea and leg discomfort were rated on specific modified Borg scales.</p></div><div><h3>Results</h3><p>The mean walk distance in 6MWT was 494<!--> <!-->±<!--> <!-->88<!--> <!-->m. The Borg scale rating for shortness of breath upon completing the test was 4.7<!--> <!-->±<!--> <!-->2, whilst 2.9<!--> <!-->±<!--> <!-->2 for leg discomfort. IC changed from 2.53<!--> <!-->±<!--> <!-->0.63<!--> <!-->l before to 2.34<!--> <!-->±<!--> <!-->0.60<!--> <!-->l after completion of the test.</p><p>In the treadmill CPET, maximal oxygen consumption (<span><math><mrow><mover><mtext>V</mtext><mo>˙</mo></mover><msub><mtext>O</mtext><mn>2</mn></msub><mtext></mtext><mi>max</mi></mrow></math></span>) was 21.8<!--> <!-->±<!--> <!-->5<!--> <!-->mL/kg/min with 6.6<!--> <!-->±<!--> <!-->2 dyspnea and 4.3<!--> <!-->±<!--> <!-->2 leg discomfort on Borg scales. IC changed from 2.17<!--> <!-->±<!--> <!-->0.53<!--> <!-->l to 1.20<!--> <!-->±<!--> <!-->0.43<!--> <!-->l.</p></div><div><h3>Conclusions</h3><p>Dynamic hyperinflation occurs in male COPD patients during submaximal exercise such as the 6MWT. This phenomenon is more pronounced after incremental CPET on a treadmill. Despite being dyspnea the dominant limiting symptom for both tests, we observed different physiological responses.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 5","pages":"Pages 266-272"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.04.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35058110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Does any association exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED study 慢性阻塞性肺疾病和勃起功能障碍之间是否存在关联?解码研究
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-09-01 DOI: 10.1016/j.rppnen.2017.04.005
M. Dias , M.J. Oliveira , P. Oliveira , I. Ladeira , R. Lima , M. Guimarães
{"title":"Does any association exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED study","authors":"M. Dias ,&nbsp;M.J. Oliveira ,&nbsp;P. Oliveira ,&nbsp;I. Ladeira ,&nbsp;R. Lima ,&nbsp;M. Guimarães","doi":"10.1016/j.rppnen.2017.04.005","DOIUrl":"10.1016/j.rppnen.2017.04.005","url":null,"abstract":"<div><h3>Introduction</h3><p>Erectile dysfunction (ED) is the inability to achieve or maintain an erection for satisfactory sexual activity. Recent studies have shown an association between ED and chronic obstructive pulmonary disease (COPD). However, this issue is often ignored. We aimed to evaluate the ED prevalence in COPD patients and its risk factors and to study the impact of dyspnea in sexual activity.</p></div><div><h3>Methods</h3><p>Cross-sectional study that included sexually active male patients with COPD. The International Index of Erectile Function (IIEF-5) questionnaire evaluated ED and the Respiratory Experiences with Sexuality Profile (RESP) was used to evaluate the impact of dyspnea on sexual activity. Risk factors for mild-moderate or moderate ED were determined using logistic regression.</p></div><div><h3>Results</h3><p>84 patients were consecutively assessed for eligibility, 67 were included (median age: 65 years, 13% never-smokers). Twenty two percent had COPD 2011-GOLD A; 22% GOLD B, 14% GOLD C and 42% GOLD D. Fifty-eight patients (87%) had some degree of ED: 26 (45%) mild, 20 (34%) mild-moderate and 12 (21%) moderate ED. ED occurred in all GOLD stages of COPD, mainly in GOLD B and D stages. Higher CAT score was independently associated to mild-moderate/moderate ED. Most patients (85%) reported dyspnea during their sexual activity but 72% had never talked about it with their physician.</p></div><div><h3>Conclusions</h3><p>ED is highly prevalent among COPD patients and it is more severe in patients with higher CAT scores. Dyspnea affects their sexual activity but this is not a topic often discussed between patients and doctors, something which needs to be improved.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 5","pages":"Pages 259-265"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.04.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35096540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Measuring sarcoidosis around the world: Using the same ruler 测量世界范围内的结节病:使用相同的尺子
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-09-01 DOI: 10.1016/j.rppnen.2017.08.001
R.P. Baughman, E.E. Lower
{"title":"Measuring sarcoidosis around the world: Using the same ruler","authors":"R.P. Baughman,&nbsp;E.E. Lower","doi":"10.1016/j.rppnen.2017.08.001","DOIUrl":"10.1016/j.rppnen.2017.08.001","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 5","pages":"Pages 247-248"},"PeriodicalIF":0.0,"publicationDate":"2017-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.08.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35347532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Pleural effusion in AA amyloidosis – A rare involvement of a rare disease AA型淀粉样变性的胸腔积液-罕见疾病的罕见累及
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-07-01 DOI: 10.1016/j.rppnen.2017.03.001
C. Dias, I. Tavares, A. Magalhães, N. Melo
{"title":"Pleural effusion in AA amyloidosis – A rare involvement of a rare disease","authors":"C. Dias,&nbsp;I. Tavares,&nbsp;A. Magalhães,&nbsp;N. Melo","doi":"10.1016/j.rppnen.2017.03.001","DOIUrl":"10.1016/j.rppnen.2017.03.001","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 234-236"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34929396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What exactly Portuguese respiratory professionals aim for their scientific Society: Findings from the VOICE online survey 葡萄牙呼吸系统专业人士对其科学学会的目标究竟是什么:VOICE在线调查的结果
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-07-01 DOI: 10.1016/j.rppnen.2017.02.008
J.C. Winck , S. Moreira , A. Bugalho , M. Drummond , A.J. Ferreira , M. Guimarães , J.M. Reis-Ferreira
{"title":"What exactly Portuguese respiratory professionals aim for their scientific Society: Findings from the VOICE online survey","authors":"J.C. Winck ,&nbsp;S. Moreira ,&nbsp;A. Bugalho ,&nbsp;M. Drummond ,&nbsp;A.J. Ferreira ,&nbsp;M. Guimarães ,&nbsp;J.M. Reis-Ferreira","doi":"10.1016/j.rppnen.2017.02.008","DOIUrl":"10.1016/j.rppnen.2017.02.008","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 225-226"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.02.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34898339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Children's second-hand tobacco smoke exposure: the silent killer 儿童二手烟暴露:无声杀手
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-07-01 DOI: 10.1016/j.rppnen.2017.06.002
C.A. Jimenez-Ruiz
{"title":"Children's second-hand tobacco smoke exposure: the silent killer","authors":"C.A. Jimenez-Ruiz","doi":"10.1016/j.rppnen.2017.06.002","DOIUrl":"10.1016/j.rppnen.2017.06.002","url":null,"abstract":"","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 175-176"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35125760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Physical performance, quality of life and sexual satisfaction evaluation in adults with cystic fibrosis: An unexplored correlation 囊性纤维化成人患者的身体表现、生活质量和性满意度评估:一种未探索的相关性
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-07-01 DOI: 10.1016/j.rppnen.2017.02.009
K.C.A. Aguiar , F.A.L. Marson , C.C.S. Gomez , M.C. Pereira , I.A. Paschoal , A.F. Ribeiro , J.D. Ribeiro
{"title":"Physical performance, quality of life and sexual satisfaction evaluation in adults with cystic fibrosis: An unexplored correlation","authors":"K.C.A. Aguiar ,&nbsp;F.A.L. Marson ,&nbsp;C.C.S. Gomez ,&nbsp;M.C. Pereira ,&nbsp;I.A. Paschoal ,&nbsp;A.F. Ribeiro ,&nbsp;J.D. Ribeiro","doi":"10.1016/j.rppnen.2017.02.009","DOIUrl":"10.1016/j.rppnen.2017.02.009","url":null,"abstract":"<div><h3>Objective</h3><p>Quality of life (QOL), sexual satisfaction (SS) and physical performance have been assessed in the management of numerous chronic diseases.</p></div><div><h3>Methods</h3><p>In this study, the following tests and surveys were applied: (i) QOL questionnaire [Cystic Fibrosis Questionnaire (CFQ)]; (ii) SS questionnaire (SSQ) [female sexual quotient (FSQ) and male sexual quotient (MSQ)]; (iii) 6-minute walk test (6MWT). Spearman's correlation was used for comparison between the data; the Mann–Whitney test was applied to analyze the difference between genders. A total of 52 adult patients with CF were included in this study.</p></div><div><h3>Results</h3><p>There was a positive correlation between CFQ domains and SSQ questions. The CFQ showed a positive correlation with peripheral oxygen saturation of hemoglobin (SpO<sub>2</sub>) and the distance walked in the 6MWT, and a negative correlation with the Borg scale. The SSQ showed positive correlation with the distance walked and a negative correlation with the Borg scale. For some markers evaluated in the 6MWT, there was sometimes association with the evaluated domains and questions. Male patients showed better scores in the emotional CFQ domain, better performance in SSQ and physical performance.</p></div><div><h3>Conclusions</h3><p>There was a correlation between CFQ, SSQ and 6MWT in CF. Finally; we believe that QOL surveys should assess the domain “sexuality” as well as physical performance tests.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 179-192"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.02.009","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34938911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Titration with automatic continuous positive airway pressure in obstructive sleep apnea 自动持续气道正压滴定治疗阻塞性睡眠呼吸暂停
Revista Portuguesa de Pneumologia (English Edition) Pub Date : 2017-07-01 DOI: 10.1016/j.rppnen.2017.04.002
C. Dias , L. Sousa , L. Batata , R. Reis , F. Teixeira , J. Moita , J. Moutinho dos Santos
{"title":"Titration with automatic continuous positive airway pressure in obstructive sleep apnea","authors":"C. Dias ,&nbsp;L. Sousa ,&nbsp;L. Batata ,&nbsp;R. Reis ,&nbsp;F. Teixeira ,&nbsp;J. Moita ,&nbsp;J. Moutinho dos Santos","doi":"10.1016/j.rppnen.2017.04.002","DOIUrl":"10.1016/j.rppnen.2017.04.002","url":null,"abstract":"<div><h3>Background and objective</h3><p>Autotitrating positive airway pressure (APAP) is an accepted titration method to determine the optimal positive airway pressure (PAP), for the treatment of obstructive sleep apnea (OSA). The required duration of APAP monitoring to determine a fixed continuous positive airway pressure level still remains to be established. We aimed to evaluate the variation in PAP level, delivered by APAP devices, at different periods of treatment, to determine the APAP treatment duration required to reach an effective and stable PAP level.</p></div><div><h3>Methods</h3><p>A cross-sectional study of 62 patients newly diagnosed with OSA were evaluated after 3 months of APAP therapy. APAP data corresponding to the first day (D1), first week (W1), seventh week (W7) and twelfth week (W12) under APAP therapy was collected. For the analysis of the pressure behaviour, the difference of P95th pressure level between W12 and W7 (P W12–W7), W12 and W1 (P W12–W1) and W12 and D1 (P W12–D1) was calculated.</p></div><div><h3>Results</h3><p>There was a high correlation in P95th pressure level between D1 and W12 (<em>r</em> <!-->=<!--> <!-->0.771; <em>p</em> <!-->&gt;<!--> <!-->0.0001), W1 and W12 (<em>r</em> <!-->=<!--> <!-->0.817; <em>p</em> <!-->&gt;<!--> <!-->0.0001), and W7 and W12 (<em>r</em> <!-->=<!--> <!-->0.926; <em>p</em> <!-->&gt;<!--> <!-->0.0001). This correlation progressively increased with APAP use. A significance difference was found in concordance between P W12–W7 and P W12–D1 (<em>p</em> <!-->=<!--> <!-->0.046) within the pressure range ±2<!--> <!-->cmH<sub>2</sub>O. However there was no significant difference in concordance between P W12–W7 and P W12–W1.</p></div><div><h3>Conclusions</h3><p>One week of APAP therapy seems sufficient to determine an effective and stable PAP level, within the pressure range ±2<!--> <!-->cmH<sub>2</sub>O.</p></div>","PeriodicalId":101122,"journal":{"name":"Revista Portuguesa de Pneumologia (English Edition)","volume":"23 4","pages":"Pages 203-207"},"PeriodicalIF":0.0,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.rppnen.2017.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35076614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信